Sonnet BioTherapeutics I...

NASDAQ: SONN · Real-Time Price · USD
3.38
-0.38 (-10.11%)
At close: Aug 15, 2025, 11:19 AM

Sonnet BioTherapeutics Revenue

Sonnet BioTherapeutics reported an annual revenue of $18.63K, reflecting a -87.4% growth. For the quarter ending June 30, 2025, Sonnet BioTherapeutics generated $0 in revenue.
Revenue (ttm)
18.63K
Revenue Growth
-87.4%
Price / Sales Ratio
235.35
Revenue / Employee
1.43K
Employees
13
Market Cap
21.17M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.